Melbourne Law School at the University of Melbourne
The University is committed to hosting events and activations on its campuses in a COVIDSafe way, in accord with government restrictions and guidelines. Some of our events are presented on campus, others online – be sure to check the details. Find out more about the University’s COVIDSafe plans
There are numerous products and tools in the marketplace for artificial intelligence (AI) in medical imaging. This has spawned from many AI start-ups and companies.
How does one choose which product is suitable for use in their clinical case?
Should you do it now? Should you do it later?
There will be a discussion on what has been done at Alfred and Monash.
Will AI become less expensive?
What does it mean for the companies which have install base enterprise imaging and now enterprise AI platforms with API integration/plug ins for home grown and 3rd party AI tools/products?
What are the costs involved in running a medium to large medical imaging department? From equipment to infrastructure, to staff and service agreements.
What are the costs of AI products?
What is the return on this investment and how does it improve costs, workflow, quality of care, and patient safety in a radiology department?
How should we engage the consumers/patients?
Do we need to tell them we are using AI to help with their diagnosis and clinical care?
Do we need patient consent to use AI in their care?
What are the issues with using patient data to develop AI products and do we need consent if we develop products that becomes commercial products? Essentially monetizing a patient’s digital health data. Are patients entitled to a share of the commercial products’ revenue?
We may discuss data brokers, consent access to data, block chain consent. Most patients are happy with their digital health data being used for clinical care or even for research purposes, however it becomes a different discussion if their data is being used for commercial purposes.
**Please note new date Thursday 20 January**
The marrying of mindfulness and the creative process can inspire enhanced visualisation, flow, and awareness, and can be a fertile ground for a fulfilling artistic practice. Whilst the many benefits of mindfulness are well known, incorporating different meditation traditions can transform a meditation practice, as exemplified by the current Presence of Mind exhibition at Gallery Lane Cove which explores how meditation practices from religious and non-religious sources influence creative practice.
For contemplative science, too, meditation has a complex range of techniques, uses, and effects. Meditation not only supports personal and community wellbeing but can enhance creativity in non-artists.
We invite you to join our engaging panel of artists, meditation practitioners, and researchers to explore current research and intimate personal stories about how mindfulness can nurture creativity.
This event is brought to you by the Contemplative Studies Centre, University of Melbourne, and Gallery Lane Cove as part of Presence of Mind’s public program. Presence of Mind is an exhibition supported by the Australian Council for the Arts and Create NSW and is on view at Gallery Lane Cove from 11 December 2021 – 26 February 2022. This event will also be recorded for The Art Show on ABC Radio National.
Image credit: Kath Fries, Hold dear, 2011-2021, (detail view).